These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 24491548)

  • 1. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
    Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
    J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins.
    Ha JH; Won EY; Shin JS; Jang M; Ryu KS; Bae KH; Park SG; Park BC; Yoon HS; Chi SW
    J Am Chem Soc; 2011 Feb; 133(5):1244-7. PubMed ID: 21210687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif.
    Xu H; Ye H; Osman NE; Sadler K; Won EY; Chi SW; Yoon HS
    Biochemistry; 2009 Dec; 48(51):12159-68. PubMed ID: 19916559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved mechanism for binding of p53 DNA-binding domain and anti-apoptotic Bcl-2 family proteins.
    Lee DH; Ha JH; Kim Y; Jang M; Park SJ; Yoon HS; Kim EH; Bae KH; Park BC; Park SG; Yi GS; Chi SW
    Mol Cells; 2014 Mar; 37(3):264-9. PubMed ID: 24646834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
    Modi V; Sankararamakrishnan R
    J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
    Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
    Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.
    Zhao RN; Fan S; Han JG; Liu G
    J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism of irinotecan targeting MDM2 and Bcl-xL.
    Lee B; Min JA; Nashed A; Lee SO; Yoo JC; Chi SW; Yi GS
    Biochem Biophys Res Commun; 2019 Jun; 514(2):518-523. PubMed ID: 31056264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
    Moroy G; Martin E; Dejaegere A; Stote RH
    J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
    Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
    Foight GW; Keating AE
    J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.
    Dutta S; Gullá S; Chen TS; Fire E; Grant RA; Keating AE
    J Mol Biol; 2010 May; 398(5):747-62. PubMed ID: 20363230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
    Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
    Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.